Biodeal Pharmaceuticals Limited has been officially awarded the Uzbekistan GMP Certification by the Center of Good Practices, Ministry of Health, Republic of Uzbekistan. The certification, valid till October 2028, reaffirms Biodeal’s commitment to global quality standards, advanced manufacturing excellence, and healthcare innovation. This achievement reflects the company’s robust quality systems, state-of-the-art infrastructure, and unwavering dedication to delivering safe, effective, and trusted pharmaceutical products to global markets.
This milestone stands as a proud moment for the entire Biodeal team. It has been made possible through the collective effort, collaboration, and discipline of every department working together toward a shared vision of excellence. The certification not only validates Biodeal’s operational strength but also reinforces its position as a globally trusted name in the pharmaceutical industry, driven by innovation and integrity.
Sharing his thoughts on this achievement, Mr. Anurag Kumar, Managing Director, Biodeal Pharmaceuticals Limited, said, “Proud moment for all Biodeal members — we have received Uzbekistan GMP for another 3 years, valid till October 2028. All this became possible through the teamwork of every department. My heartfelt thanks to each one of you!” With this recognition, Biodeal continues to strengthen its global footprint and uphold its mission to contribute to a healthier world through consistent quality, innovation, and trust.
#BiodealPharmaceuticals #UzbekistanGMP #PharmaLeadership #QualityMatters #GlobalCompliance #PharmaceuticalIndustry #ManufacturingExcellence #TeamBiodeal #HealthcareInnovation #CommitmentToQuality